MRK investigational once-weekly oral hiv treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with h
MRK investigational once-weekly oral hiv treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with hiv who switched antiretroviral therapy
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.